Document is current
Any future updates will be listed below
-
Authors
Stringer-Reasor, Erica M.
Saha, Poornima
Kocherginsky, Masha
Lastra, Ricardo
Baker, Gabrielle
Lenygel, Ernst
Karrison, Theodore
Olalde, Lauren
Mokrzycki, Elizabeth
Hahn, Olwen M.
Hoffman, Philip C.
Conzen, Suzanne D.
Fleming, Gini F.
Nanda, Rita
-
Funding
Funding for this research was provided by:
Conquer Cancer Foundation ASCO Young Investigator Award
Basic Research Training in Medical Oncology Grant (T32CA009566)
NIH Clinical Therapeutics Training Grant (T32GM007019)
Corcept Therapeutics for supplying mifepristone
University of Chicago Comprehensive Cancer Center Women’s Board Funding
University of Chicago Comprehensive Cancer Center Protocol Specific Research Grant (NIH CA014599, NIH CA014599)
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 9 July 2025
First Online: 8 August 2025
Declarations
:
: SC and MK are co-inventors on a patent licensed by the University of Chicago to Corcept Therapeutics.
